From July 1, 2023 to September 30, 2023, the company has repurchased 1,200,664 shares, representing 0.95% for $1.29 million. With this, the company has completed the repurchase of 1,320,046 shares, representing 1.04% for $1.44 million under the buyback announced on June 27, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.73 USD | +4.22% | +13.07% | +96.59% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+96.59% | 208M | |
+22.79% | 47.9B | |
+46.56% | 41.42B | |
-1.88% | 40.7B | |
-6.20% | 28.92B | |
+11.39% | 25.55B | |
-21.08% | 19.27B | |
-1.41% | 12.15B | |
+30.52% | 12.14B | |
-0.48% | 11.99B |
- Stock Market
- Equities
- ATOS Stock
- News Atossa Therapeutics, Inc.
- Tranche Update on Atossa Therapeutics, Inc.'s Equity Buyback Plan announced on June 27, 2023.